CAS No.:341031-54-7

TOXICITY DATA with REFERENCE：

 

Consensus Reports：

 

SAFETY PROFILE：

 

Standards and Recommendations：

 

Analytical Methods：

Sunitinib inhibits cellular signaling by targeting multiple receptor tyrosine kinases.These include all receptors for platelet-derived growth factor  and vascular endothelial growth factor receptors ,which play a role in both tumor angiogenesis and tumor cell proliferation. The simultaneous inhibition of these targets therefore leads to both reduced tumor vascularization and cancer cell death, and ultimately tumor shrinkage.